logo

Aikido Pharma Inc. (AIKI)



Trade AIKI now with
  Date
  Headline
4/7/2021 9:08:40 AM AIkido Secures Sublicense To Technology For Targeted Psilocybin Treatment Of Neuro-Inflamed Tissue In Cancer Patients
4/5/2021 9:06:08 AM AIkido Pharma Says Sufficiently Capitalized To Support Current Efforts And To Pursue Additional Emerging Opportunities
2/19/2021 11:16:33 AM AIkido Pharma Announces Closing Of $75 Mln Bought Deal Offering Of Common Stock
2/16/2021 10:16:18 PM AIkido Pharma Increases Bought Deal Offering Of Common Stock To $75 Mln
2/16/2021 8:38:55 AM AIkido Pharma Enters Into LoI With Silo Pharma For Use Of Psilocybin And Peptide Therapy For Cancer Treatment
1/22/2021 1:44:26 PM AIkido Pharma Regains Compliance With NASDAQ Listing Requirements
1/6/2021 8:17:11 AM AIkido Pharma Executes Licensing Agreement For Psilocybin For Cancer Applications
11/20/2020 8:09:15 AM AIkido Pharma : All Stockholder Proposals Approved Other Than Authority For Reverse Stock Spilt